Altering Metabolic Profiles of Drugs by Precision Deuteration 2: Discovery of a Deuterated Analog of Ivacaftor with Differentiated Pharmacokinetics for Clinical Development
Harbeson, Scott L, Morgan, Adam J, Liu, Julie F, Aslanian, Ara M, Nguyen, Sophia, Bridson, Gary W, Brummel, Christopher L, Wu, Lijun, Tung, Roger D, Pilja, Lana, Braman, Virginia, Uttamsingh, Vinita
Published in The Journal of pharmacology and experimental therapeutics (01.08.2017)
Published in The Journal of pharmacology and experimental therapeutics (01.08.2017)
Get full text
Journal Article
Phase I evaluation of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies
Ansell, Stephen Maxted, Northfelt, Donald W., Flinn, Ian, Burris, Howard A., Dinner, Shira Naomi, Villalobos, Victor Manuel, Sikic, Branimir I., Taylor, Matthew Hiram, Pilja, Lana, Hawthorne, Thomas R., Yellin, Michael Jay, Keler, Tibor, Davis, Thomas A.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Immunologic activity of an activating anti-CD27 antibody (CDX-1127) in patients (pts) with solid tumors
Infante, Jeffrey R., Burris, Howard A., Ansell, Stephen Maxted, Nemunaitis, John J., Weiss, Geoffrey R., Villalobos, Victor Manuel, Sikic, Branimir I., Taylor, Matthew Hiram, Northfelt, Donald W., Carson, William Edgar, Pilja, Lana, Hawthorne, Thomas R., Davis, Thomas A., Yellin, Michael Jay, Keler, Tibor, Bullock, Timothy
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
Ansell, Stephen, Northfelt, Donald, Flinn, Ian, Burris, Howard, Dinner, Shira, Villalobos, Victor, Sikic, Branimir, Pilja, Lana, Yellin, Michael, Keler, Tibor, Davis, Thomas
Published in Journal for immunotherapy of cancer (07.11.2013)
Published in Journal for immunotherapy of cancer (07.11.2013)
Get full text
Journal Article
A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
Burris, Howard, Ansell, Stephen, Neumanitis, John, Weiss, Geoffrey, Sikic, Branimir, Northfelt, Donald, Pilja, Lana, Davis, Thomas, Yellin, Michael, Keler, Tibor, Bullock, Timothy
Published in Journal for immunotherapy of cancer (07.11.2013)
Published in Journal for immunotherapy of cancer (07.11.2013)
Get full text
Journal Article